Pena‐Shokeir phenotype (Fetal akinesia deformation sequence) revisited
- 12 August 2009
- journal article
- review article
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 85 (8) , 677-694
Abstract
BACKGROUND: Pena and Shokeir described the phenotype of two sisters in 1974, and subsequently their features have become recognized as a sequence of deformational changes related to decreased or absent fetal movement (fetal akinesia deformation sequence [FADS]), because of the work of Moessinger (1983). METHODS: Identification of reported cases by searching Online Mendelian Inheritance in Man, Medlines, the London Dysmorphology Database, and the references found in these articles. These case reports were reviewed, tabulated, and summarized. RESULTS: It is now possible to recognize at least 20 familial types of Pena‐Shokeir phenotype (PSP), based on the differences found in the reports of the natural history and pathology found at fetal and newborn autopsy. In addition, characteristic changes in the central nervous system seen with embryonic/fetal vascular compromise have been recognized in many reported cases. Most of the reported cases of PSP/FADS related to vascular compromise are sporadic, but familial cases have also been reported. CONCLUSION: Lack of fetal movement (fetal akinesia) in humans produces a recognizable sequence of deformations. Many developmental processes must be accomplished for fetal movement to be normal, and for extra‐uterine life to be sustainable. Prenatal diagnosis is possible through real‐time ultrasound studies as early as 12 weeks. Most reported cases die in utero, at birth, or in the newborn period. Advances in embryo/fetus pathology have led to the recognition of the many familial subtypes, allowing improved genetic counseling and early recognition in subsequent pregnancies. Birth Defects Research (Part A), 2009.Keywords
This publication has 119 references indexed in Scilit:
- Mutations in mRNA export mediator GLE1 result in a fetal motoneuron diseaseNature Genetics, 2008
- Lethal Contractural Syndrome Type 3 (LCCS3) Is Caused by a Mutation in PIP5K1C, Which Encodes PIPKIγ of the Phophatidylinsitol PathwayThe American Journal of Human Genetics, 2007
- Lethal Congenital Contractural Syndrome Type 2 (LCCS2) Is Caused by a Mutation in ERBB3 (Her3), a Modulator of the Phosphatidylinositol-3-Kinase/Akt PathwayThe American Journal of Human Genetics, 2007
- Mutations in Cytokine Receptor-Like Factor 1 (CRLF1) Account for Both Crisponi and Cold-Induced Sweating SyndromesThe American Journal of Human Genetics, 2007
- Multiple ankyloses, facial anomalies, and pulmonary hypoplasia associated with severe antenatal spinal muscular atrophyThe Journal of Pediatrics, 1983
- Contractures in a newborn infant of a mother with myasthenia gravisThe Journal of Pediatrics, 1980
- Arthrogryposis multiplex congenita-prenatal assessment with diagnostic ultrasound and fetoscopyThe Journal of Pediatrics, 1979
- Syndrome of camptodactyly, facial anomalies, and pulmonary hypoplasiaThe Journal of Pediatrics, 1978
- Syndrome of ankylosis, facial anomalies, and pulmonary hypoplasiaThe Journal of Pediatrics, 1974
- Syndrome of camptodactyly, multiple ankyloses, facial anomalies, and pulmonary hypoplasia: A lethal conditionThe Journal of Pediatrics, 1974